TGFB1 and diabetes mellitus: The TGF-β1 levels were significantly higher (by 3.7-fold) (Fig. 1C) in diabetic BALF compared to those in the controls, indicating that diabetes-induced pathological changes may involve the activation of TGF-β1 signaling pathways.